- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Teduglutide – March 2019
Teduglutide: Powder for injection 5 mg with diluent; Revestive®
Last updated
5 July 2019